Latest Ratios: P/E Ratio 5494.6x · EV/EBITDA 290.5x · ROE 0.4%. (1995–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $16.8B | $10.9B | $8.2B | $9.6B | $9.1B | $11.0B | $6.5B | $2.6B | $876M | $709M | $883M |
| Enterprise Value | $16.7B | $10.8B | $8.0B | $9.5B | $9.1B | $11.0B | $6.5B | $2.7B | $1.0B | $903M | $1.1B |
| P/E Ratio → | 5494.62 | 3526.91 | 134.00 | 37.29 | 51.09 | 115.01 | 134.76 | 59.81 | — | — | — |
| P/S Ratio | 32.08 | 20.78 | 16.01 | 13.08 | 13.82 | 21.26 | 15.86 | 6.50 | 2.20 | 1.84 | 2.07 |
| P/B Ratio | 23.72 | 15.23 | 11.47 | 13.94 | 18.73 | 26.61 | 16.84 | 8.02 | 3.39 | 3.26 | 3.27 |
| P/FCF | 126.62 | 82.01 | 68.02 | 38.66 | 42.36 | 69.38 | 81.36 | 24.21 | 25.06 | 43.98 | 55.26 |
| P/OCF | 95.87 | 62.09 | 57.89 | 35.77 | 38.22 | 65.31 | 70.60 | 21.17 | 17.02 | 18.41 | 21.16 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 20.67 | 15.77 | 12.95 | 13.83 | 21.36 | 15.89 | 6.64 | 2.55 | 2.34 | 2.60 |
| EV / EBITDA | 290.53 | 187.82 | 99.53 | 37.65 | 40.90 | 83.48 | 77.69 | 27.40 | 28.60 | 88.22 | 31.65 |
| EV / EBIT | 1095.31 | 792.96 | 132.41 | 44.56 | 47.94 | 106.92 | 124.33 | 47.22 | — | — | — |
| EV / FCF | — | 81.59 | 67.01 | 38.25 | 42.37 | 69.70 | 81.50 | 24.71 | 29.08 | 56.03 | 69.53 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.2% | 68.2% | 66.8% | 69.8% | 68.5% | 62.4% | 60.1% | 59.0% | 55.0% | 56.1% | 57.7% |
| Operating Margin | 2.9% | 2.9% | 6.8% | 28.8% | 28.4% | 19.6% | 12.8% | 14.6% | -0.8% | -12.3% | -6.3% |
| Net Profit Margin | 0.6% | 0.6% | 12.0% | 35.1% | 27.1% | 18.6% | 11.6% | 10.8% | -6.6% | -18.3% | -12.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.4% | 0.4% | 8.7% | 43.9% | 39.8% | 24.1% | 13.3% | 14.8% | -11.1% | -28.9% | -18.8% |
| ROA | 0.4% | 0.4% | 7.3% | 31.6% | 23.5% | 13.6% | 7.3% | 7.0% | -4.2% | -10.1% | -7.0% |
| ROIC | 1.8% | 1.8% | 4.4% | 29.5% | 29.5% | 17.6% | 10.1% | 11.3% | -0.6% | -8.0% | -3.9% |
| ROCE | 2.0% | 2.0% | 4.6% | 30.0% | 29.0% | 16.5% | 9.4% | 11.1% | -0.6% | -8.1% | -4.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.11 | 0.11 | 0.02 | 0.04 | 0.31 | 0.44 | 0.50 | 0.53 | 1.00 | 1.38 | 1.24 |
| Debt / EBITDA | 1.36 | 1.36 | 0.19 | 0.11 | 0.67 | 1.39 | 2.32 | 1.76 | 7.31 | 29.41 | 9.53 |
| Net Debt / Equity | — | -0.08 | -0.17 | -0.15 | 0.01 | 0.12 | 0.03 | 0.17 | 0.54 | 0.89 | 0.84 |
| Net Debt / EBITDA | -0.97 | -0.97 | -1.50 | -0.40 | 0.01 | 0.39 | 0.14 | 0.56 | 3.96 | 18.98 | 6.50 |
| Debt / FCF | — | -0.42 | -1.01 | -0.41 | 0.01 | 0.32 | 0.14 | 0.50 | 4.02 | 12.05 | 14.27 |
| Interest Coverage | 51.67 | 51.67 | 228.11 | 72.19 | 45.93 | 37.59 | 14.09 | 4.84 | -0.16 | -2.71 | -1.17 |
Net cash position: cash ($134M) exceeds total debt ($78M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.09 | 3.09 | 3.66 | 3.78 | 2.98 | 2.84 | 4.19 | 2.63 | 4.10 | 3.15 | 2.25 |
| Quick Ratio | 2.33 | 2.33 | 2.62 | 2.76 | 2.11 | 2.20 | 3.38 | 2.08 | 3.13 | 2.19 | 1.69 |
| Cash Ratio | 1.14 | 1.14 | 1.37 | 1.32 | 1.14 | 1.24 | 2.29 | 1.18 | 1.85 | 1.34 | 0.84 |
| Asset Turnover | — | 0.59 | 0.60 | 0.88 | 0.83 | 0.71 | 0.60 | 0.66 | 0.64 | 0.61 | 0.56 |
| Inventory Turnover | 1.86 | 1.86 | 1.63 | 2.25 | 1.89 | 2.86 | 2.52 | 3.01 | 2.67 | 2.12 | 2.28 |
| Days Sales Outstanding | — | 71.34 | 58.08 | 51.68 | 51.97 | 56.56 | 57.76 | 58.64 | 55.73 | 52.11 | 85.16 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.0% | 0.0% | 0.7% | 2.7% | 2.0% | 0.9% | 0.7% | 1.7% | — | — | — |
| FCF Yield | 0.8% | 1.2% | 1.5% | 2.6% | 2.4% | 1.4% | 1.2% | 4.1% | 4.0% | 2.3% | 1.8% |
| Buyback Yield | 0.6% | 0.9% | 0.8% | 0.8% | 1.2% | 0.6% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.6% | 0.9% | 0.8% | 0.8% | 1.2% | 0.6% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $138M | $138M | $140M | $141M | $142M | $141M | $137M | $127M | $123M | $120M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LSCC stock.
Lattice Semiconductor Corporation's current P/E ratio is 5494.6x. The historical average is 45.8x. This places it at the 100th percentile of its historical range.
Lattice Semiconductor Corporation's current EV/EBITDA is 290.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 36.1x.
Lattice Semiconductor Corporation's return on equity (ROE) is 0.4%. The historical average is 1.3%.
Based on historical data, Lattice Semiconductor Corporation is trading at a P/E of 5494.6x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Lattice Semiconductor Corporation has 68.2% gross margin and 2.9% operating margin.
Lattice Semiconductor Corporation's Debt/EBITDA ratio is 1.4x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Margin compression despite revenue growth
Metrics are mathematically derived from official filings.
Gross Margin Strength, Operating Drag
LSCC's gross margin expanded to 70.3% in 2026Q2, up from 61.1% in 2024Q4, but operating margin remains compressed at 11.1%, reflecting heavy R&D investment, according to recent financial statements.
The gross margin trajectory underscores the pricing power of LSCC's low-power FPGA portfolio, yet the operating margin is still well below the 18.2% seen in 2024Q2, indicating that R&D spending for the Avant platform is outpacing revenue scale. Net margin of 9.6% in 2026Q2 is recovering from negative territory in 2025Q4, but the gap between gross and operating margins suggests that the company is deliberately sacrificing near-term profitability to fund future growth. Investors should monitor whether operating leverage materializes as revenue scales, or if the elevated expense base becomes structural.
Return on Capital Inflecting Upward
ROIC improved to 2.6% in 2026Q2 from -1.5% in 2024Q4, but remains far below the cost of capital, as per the ratio data, indicating that the recent revenue surge has yet to translate into meaningful capital efficiency.
The sharp swing in ROIC from negative to positive is a positive signal, but the absolute level is still low, reflecting the heavy investment in R&D and working capital. ROE of 2.5% and ROA of 2.1% are similarly modest, suggesting that the company is still in the early stages of recovering from the cyclical trough. The improvement is driven by margin recovery rather than asset turnover, which remains low at 0.21, consistent with a fabless model that carries significant intangible assets. If the Avant platform gains traction, ROIC could rise substantially, but the current data suggests that capital efficiency is still subpar.
Working Capital Cycle Compressing
LSCC's cash conversion cycle compressed to 93 days in 2026Q2 from 205 days in 2025Q2, driven by faster collections and lower inventory days, according to the quarterly ratio data, signaling improved working capital management.
The reduction in DSO from 62 to 55 days and DIO from 219 to 144 days over the past year indicates that the company is managing its receivables and inventory more tightly, possibly reflecting a shift in product mix or better channel discipline. DPO increased to 106 days, suggesting LSCC is stretching payables, which is typical for a fabless company with negotiating power over suppliers. The overall CCC compression is a positive sign, but the volatility in DIO (which swung from 238 days in 2024Q3 to 144 days in 2026Q2) warrants monitoring, as it could indicate inventory build-ups or corrections. The improvement in working capital efficiency is a key driver of the strong cash flow generation seen in 2026Q2.
Minimal Debt, Ample Flexibility
LSCC's debt-to-equity ratio remains negligible at 0.05, with interest coverage of 196.65 in 2026Q2, according to the balance sheet data, indicating a fortress-like balance sheet that provides substantial financial flexibility.
The company's low leverage is a strategic asset, especially in a cyclical industry, as it allows LSCC to continue investing in R&D and weather potential downturns without the risk of covenant breaches or refinancing pressure. The slight increase in total debt to $38.1M is immaterial relative to equity of $787.5M, and the interest coverage ratio is exceptionally high, suggesting that debt service is not a concern. This financial strength may also enable opportunistic share buybacks or acquisitions, though management has historically favored organic investment. The clean balance sheet is a key differentiator versus peers like MCHP, which carries a D/E of 0.86.
Liquidity Buffer Remains Strong
LSCC's current ratio stands at 3.02 and quick ratio at 2.33 in 2026Q2, down from 4.18 and 3.01 in 2024Q1, but still robust, as per the ratio data, indicating ample liquidity to cover short-term obligations.
The decline in the current ratio is partly due to increased inventory and payables, but the absolute levels remain healthy, with cash and short-term investments providing a significant cushion. The quick ratio of 2.33 suggests that even if inventory becomes obsolete, LSCC can cover its current liabilities without relying on inventory liquidation. This liquidity position is consistent with the company's fabless model, which requires less working capital than integrated manufacturers. Under a severe demand shock, the company could likely sustain operations for several quarters without external financing, given its low fixed costs and minimal debt.
Misapplied P/E on Cyclical Earnings
The trailing P/E of 5796.86 is misleading due to depressed TTM earnings, while the forward P/E of 123.08 better reflects the expected earnings recovery, but still appears rich, based on reported valuation multiples.
The most commonly misapplied ratio for LSCC is the trailing P/E, which is distorted by the cyclical trough in earnings. With TTM net margin of only 0.59%, the P/E is astronomically high, but this does not reflect the company's normalized earning power. Investors should instead use EV/EBITDA or forward P/E, which incorporate the expected recovery. However, even the forward EV/EBITDA of 133.94 is elevated relative to peers like MCHP (41.06) and AMAT (51.79), suggesting that the market is pricing in a significant growth inflection. The risk is that if the recovery stalls, the stock could de-rate sharply. A more appropriate valuation metric might be EV/Sales, given the variability in margins, but even that is high at 33.85.